In-depth clinical and biological exploration of DNA Damage Immune Response (DDIR) as a biomarker for oxaliplatin use in colorectal cancer

Sudhir B. Malla, David Fisher, Enric Domingo, Andrew Blake, Sylvana Hassanieh, Keara L Redmond, Susan D Richman, Michael Youdell, Steven Walker, Gemma E Logan, Aikaterini Chatzipli, Raheleh Amirkhah, Matthew Phlip Humphries, Stephanie G Craig, Ultan Mcdermott, Matthew T Seymour, Dion G Morton, Philip Quirke, Nicholas P West, Manuel Salto-tellezRichard D Kennedy, Patrick G Johnston, Ian Tomlinson, Viktor H Koelzer, Leticia Campo, Richard S Kaplan, Daniel B. Longley, Mark Lawler, Timothy Stanley Maughan, Louise Brown, Philip D. Dunne

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)clincanres.3237.2020
JournalClinical Cancer Research
Publication statusPublished - 7 Oct 2020

Cite this